N-linked Glycosylation is Essential for the Stability but Not the Signaling Function of the Interleukin-6 Signal Transducer Glycoprotein 130
Overview
Authors
Affiliations
N-Linked glycosylation is an important determinant of protein structure and function. The interleukin-6 signal transducer glycoprotein 130 (gp130) is a common co-receptor for cytokines of the interleukin (IL)-6 family and is N-glycosylated at 9 of 11 potential sites. Whereas N-glycosylation of the extracellular domains D1-D3 of gp130 has been shown to be dispensable for binding of the gp130 ligand IL-6 and its cognate receptor in vitro, the role of the N-linked glycans on domains D4 and D6 is still unclear. We have mutated the asparagines of all nine functional N-glycosylation sites of gp130 to glutamine and systematically analyzed the consequences of deleted N-glycosylation (dNG) in both cellular gp130 and in a soluble gp130-IgG1-Fc fusion protein (sgp130Fc). Our results show that sgp130Fc-dNG is inherently unstable and degrades rapidly under conditions that do not harm wild-type sgp130Fc. Consistently, the bulk of cellular gp130-dNG is not transported to the plasma membrane but is degraded in the proteasome. However, the small quantities of gp130-dNG, which do reach the cell surface, are still able to activate the key gp130 signaling target signal transducer and activator of transcription-3 (STAT3) upon binding of the agonistic complex of IL-6 and soluble IL-6 receptor. In conclusion, N-linked glycosylation is required for the stability but not the signal-transducing function of gp130.
Kondo M, Sawada K, Matsuda Y, Abe M, Sanechika N, Takanashi Y Biomedicines. 2024; 12(8).
PMID: 39200235 PMC: 11351524. DOI: 10.3390/biomedicines12081771.
ART1 knockdown decreases the IL-6-induced proliferation of colorectal cancer cells.
Lin T, Zhang S, Tang Y, Xiao M, Li M, Gong H BMC Cancer. 2024; 24(1):354.
PMID: 38504172 PMC: 10953198. DOI: 10.1186/s12885-024-12120-0.
Expression and Clinical Significance of Plasma miR-223 in Patients with Diabetic Nephropathy.
Guo X, Huang M, Yang D, Luo Z Int J Endocrinol. 2024; 2023:9663320.
PMID: 38179188 PMC: 10764645. DOI: 10.1155/2023/9663320.
Li X, Wang J, Li Y, He W, Cheng Q, Liu X Croat Med J. 2023; 64(3):149-163.
PMID: 37391912 PMC: 10332293.
Zhao P, Hu Y, Hu J, Li C, Huang Y, Zhang L Front Genet. 2023; 14:930692.
PMID: 37152991 PMC: 10154465. DOI: 10.3389/fgene.2023.930692.